BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 17, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for October 29, 2024

Oct. 29, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiawave, Cardiosense, Cleerly, Egnite, Elixir, Medtronic, Mitrassist Lifesciences.
Read More

In the clinic for October 29, 2024

Oct. 29, 2024
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Forsee, J Ints Bio, Minghui, Zai Lab, Hope Medicines, Everest Medicines, Otsuka, Simcere.
Read More

In the clinic for Oct. 28, 2024

Oct. 28, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aquestive, Ardelyx , Bloomsbury, Dermavant, Eli Lilly, Endo, Johnson & Johnson, Leo,  Maze, Micurx, Relief, Revolution, Simcere, Tyra.
Read More

In the clinic for October 28, 2024

Oct. 28, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advanced Nanotherapies, Conavi, Corvia, Edwards, Roivios, Vahaticor.
Read More

In the clinic for Oct. 25, 2024

Oct. 25, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apogee, Arcus, Bridgebio, GSK, Hope Medicines, Intellia, J Ints, Marinus, Neurosense, Sanofi, Regeneron, Zai Lab.
Read More

In the clinic for October 25, 2024

Oct. 25, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Genedx, Seastar Medical, Skylinedx.
Read More

In the clinic for Oct. 24, 2024

Oct. 24, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkeus, Akamis, Amyra, Alto, Cyclacel, Lexicon, Opus, Oncodesign, PMV Repare, Revolution, Smart Immune, Transcode.
Read More

In the clinic for October 24, 2024

Oct. 24, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AMRA Medical, Fresenius, Grail, Seekin.
Read More

In the clinic for Oct. 23, 2024

Oct. 23, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annexon, Briacell, Clearside, Everest, Immunic, Minghui, Monopar, Oncternal, Otsuka, Quell.
Read More

In the clinic for October 23, 2024

Oct. 23, 2024
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Eyenovia, Lunit AI, Oxfored Medical.
Read More
Previous 1 2 … 69 70 71 72 73 74 75 76 77 … 326 327 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 16, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • In the clinic for June 12, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing